Link to the source article >> https://healthpolicy-watch.org/india-approves-covaxin-vaccine-for-kids-from-the-age-of-two/
The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two.
This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US.
India’s health ministry still has to approve the vaccine, which is the first to be developed in India, by Bharat Biotech in collaboration with the Indian Council of Medical Research.
Covaxin has not yet been granted emergency use listing (EUL) by the World Health Organization (WHO), but a statement issued by the WHO on Monday about last week’s meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization stated that SAGE had reviewed Covaxin’s application.
“A policy recommendation will be issued when the vaccine is Emergency Use listed by WHO,” said the report, seeming to indicate that such a listing is likely.
Return to the list of articlesWe are waiting for you!
Join us, it’s really easy! Contact us, you or your Relatives and we will advise you on how you can benefit from our support.